Literature DB >> 19224805

Patient-controlled epidural analgesia for labor.

Stephen H Halpern1, Brendan Carvalho.   

Abstract

Patient-controlled epidural analgesia (PCEA) for labor was introduced into clinical practice 20 yr ago. The PCEA technique has been shown to have significant benefits when compared with continuous epidural infusion. We conducted a systematic review using MEDLINE and EMBASE (1988-April 1, 2008) of all randomized, controlled trials in parturients who received PCEA in labor in which one of the following comparisons were made: background infusion versus none; ropivacaine versus bupivacaine; high versus low concentrations of local anesthetics; and new strategies versus standard strategies. The outcomes of interest were maternal analgesia, satisfaction, motor block, and the incidence of unscheduled clinician interventions. A continuous background infusion improved maternal analgesia and reduced unscheduled clinician interventions. Larger bolus doses (more than 5 mL) may provide better analgesia compared with small boluses. Low concentrations of bupivacaine or ropivacaine provide excellent analgesia without significant motor block. Many strategies with PCEA can provide effective labor analgesia. High volume, dilute local anesthetic solutions with a continuous background infusion appear to be the most successful strategy. Research into new delivery strategies, such as mandatory programmed intermittent boluses and computerized feedback dosing, is ongoing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224805     DOI: 10.1213/ane.0b013e3181951a7f

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  24 in total

1.  [New aspects of obstetric anesthesia].

Authors:  T Girard; S Brugger; I Hösli
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

2.  Patient intermittent epidural boluses (PIEB) plus very low continuous epidural infusion (CEI) versus patient-controlled epidural analgesia (PCEA) plus continuous epidural infusion (CEI) in primiparous labour: a randomized trial.

Authors:  Maria Belen Rodríguez-Campoó; Antonio Curto; Manuel González; Cesar Aldecoa
Journal:  J Clin Monit Comput       Date:  2018-11-30       Impact factor: 2.502

3.  [Perioperative pain management: what is evidence based?].

Authors:  D Meisenzahl; J Souquet; P Kessler
Journal:  Orthopade       Date:  2014-12       Impact factor: 1.087

4.  Programmed Intermittent Epidural Boluses (PIEB) for Maintenance of Labor Analgesia: A Superior Technique to Continuous Epidural Infusion?

Authors:  Edward T Riley; Brendan Carvalho
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-04-01

Review 5.  New Labor Pain Treatment Options.

Authors:  Veerandra Koyyalamudi; Gurleen Sidhu; Elyse M Cornett; Viet Nguyen; Carmen Labrie-Brown; Charles J Fox; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-02

6.  A Meta-Analysis of Comparing Intermittent Epidural Boluses and Continuous Epidural Infusion for Labor Analgesia.

Authors:  I-Shiang Tzeng; Ming-Chang Kao; Po-Ting Pan; Chu-Ting Chen; Han-Yu Lin; Po-Chun Hsieh; Chan-Yen Kuo; Tsung-Han Hsieh; Woon-Man Kung; Chu-Hsuan Cheng; Kuo-Hu Chen
Journal:  Int J Environ Res Public Health       Date:  2020-09-27       Impact factor: 3.390

Review 7.  Pain management for women in labour: an overview of systematic reviews.

Authors:  Leanne Jones; Mohammad Othman; Therese Dowswell; Zarko Alfirevic; Simon Gates; Mary Newburn; Susan Jordan; Tina Lavender; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

8.  Epidural analgesia for labor: Current techniques.

Authors:  Marcos Silva; Stephen H Halpern
Journal:  Local Reg Anesth       Date:  2010-12-08

9.  Advances in labor analgesia.

Authors:  Cynthia A Wong
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Patient-controlled epidural analgesia after Caesarean section: levobupivacaine 0.15% versus ropivacaine 0.15% alone or combined with fentanyl 2 µg/ml: a comparative study.

Authors:  Paraskevi Matsota; Chrysanthi Batistaki; Stylliani Apostolaki; Georgia Kostopanagiotou
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.